| Inclusion | Exclusion |
---|---|---|
Population | Adults aged 18 years or older without established or documented hypertension or CVD | Individuals < 18 years. Adults with established or documented hypertension or CVD |
Interventions | Participants are provided with information on the relative magnitude of benefits and harms of screening for hypertension using any clinic-based, home, or ambulatory blood pressure measurement. An alternative is when investigators solicit the magnitude of benefits and/or harms where screening is acceptable KQ3b: Subgroup analyses of acceptability by screening method (e.g., clinic, home, ambulatory measurement methods) | N/A |
Comparator | Depending on the study design, comparator may be no screening, another form of screening, or a different form of information that does not include the magnitude of effects for benefits and harms | N/A |
Outcomes | Acceptability measures • Willingness or intentions to screen using a given measurement method • Acceptability of screening using a given measurement method • Others as suitable (e.g., intent to return for another screen, magnitude of benefits to make screening method acceptable) | N/A |
Study design | RCTs, CCTs, observational studies with control groups that assess patient acceptability of screening | Systematic reviews, cost-effectiveness studies, qualitative studies, case report, and case series Analyses of data that were not reported by patients (e.g., databases of health records) or on outcomes outside the perspective of individuals considering screening for hypertension Studies reporting only access to screening and studies on knowledge or awareness about screening. Studies reporting only outcome prioritization, time trade-off, health state values, or willingness to pay |
Language | English and French | Any other language |
Setting | Any setting, no country-based restrictions | N/A |
Publication date | No limitation | N/A |
Study quality | No restrictions | N/A |